Fenwick & West partner Jedediah Wakefield.
The Pfizer subsidiary argued that the threat of harm, even if years in the future, should be grounds for an injunction. But Fenwick & West partner Jedediah Wakefield had argued for Loxo Oncology that Array was merely speculating.
December 30, 2019 at 07:11 PM
1 minute read
Pfizer-owned Array BioPharma Inc. has dropped claims that an Eli Lilly subsidiary and a handful of its scientists stole trade secrets.
Array dismissed its claims against Loxo Oncology Inc. on Dec. 27, six months after a Colorado judge denied Array a preliminary injunction that would have blocked the scientists from working at Loxo, and six weeks after the U.S. Court of Appeals for the Tenth Circuit sounded inclined to affirm him.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
